Other Information
+Added: On October 12, 2020, we and Osang, the manufacturer and supplier of the GeneFinder TM COVID- 19 Plus RealAmp Kit TM that we distribute, entered into a Managed Supply Agreement (the “Supply Agreement”) which memorialized of our obligations and Osang's obligations as it relates to the consignment (the “Consignment”) to us of two ( 2 ) million units of Osang's flagship Genefinder Plus RealAmp Covid- 19 PCR Test (the “Product”) from Osang for the cold-chain storage and distribution of Product in the United States of America and Canada by us on behalf of ourself, as well as for Osang to other distributors in Territory as well as for direct sales by Osang worldwide where permissible for a period of 180 days thereafter.
+Added: The Supply Agreement included confirmation by Osang that we have no payment obligation for the Consignment until we sell the Product and any unsold product remains the responsibility of Osang except that we are responsible for the sold-storage fees and Osang’s agreement to use best efforts that all sales of Products will be drawn from the Consignment with priority.
+Added: On November 12, 2020, our joint venture partnership in Clarity Mobile Venture entered into a contract with the City of Los Angeles for the operations of a COVID-19 PCR Test Laboratory at Los Angeles International Airport to provide a full-service modular COVID-19 laboratory and testing facility onsite at Los Angeles International Airport .
+Added: The facility will be located across from Terminal 6 and is expected to open in December 2020.
+Added: The facility will administer PCR tests with results available within 3 hours for passengers and airline crew, and no later than 24 hours for LAWA airport employees.
+Added: Additionally, other rapid coronavirus tests including antigen tests will be provided.
+Added: Clarity Mobile Venture will be the primary operator of the facility and will deploy the GeneFinder™ test for COVID-19, produced by OSANG Healthcare Co., Ltd.
+Added: On November 19, 2020, we and Memorial Hospital, of Michigan (“Memorial), entered into a Professional Services and Capital Support Contract (“PSCSC”) with Wayne County, Michigan to appoint Memorial the primary contractor for the construction of portable on-site laboratory facilities for COVID-19 testing.
+Added: The PSCCS engages the Company as a sub-contractor to render services and support to Memorial in connection with the fulfillment of statements of work submitted from Wayne County to Memorial.
+Added: The program deploys the D-Tec Product Series, including D-Tec 1 and D-Tec 5 facilities, designed by Grimshaw Architects and developed by SG Blocks, to deliver highly accurate PCR testing and on-site CLIA lab services directly into high risk and underserved areas.
+Added: The D-Tec 1 units are expected to be deployed throughout Wayne County and will provide sample extraction and lab services.
+Added: The D-Tec 5 will serve as the main CLIA lab and have the capacity to process 7,000 tests per day in a single eight-hour shift.
+Added: The facilities will be used to test residents for COVID-19 using the OSANG GeneFinder™ test, which is able to deliver medical grade results in approximately 3 hours.
+Added: Clarity Mobile Venture will be the primary operator of the facility.
EXHIBIT INDEX
Exhibit Number
−Removed: Underwriting Agreement dated April 1, 2020 (incorporated herein by reference to Exhibit 14.1 to the Current Report on Form 8-K as filed by SG Blocks, Inc.
−Removed: with the Securities and Exchange Commission on April 3, 2020 (File No.
−Removed: Underwriting Agreement, dated May 6, 2020, by and between SG Blocks, Inc.
−Removed: and ThinkEquity, a division of Fordham Financial Management, Inc.
+Added: Asset Purchase Agreement by and between SG Echo, LLC and Echo DCL, LLC, dated September 17, 2020.
(incorporated herein by reference to Exhibit 10.1 of the Current Report on Form 8-K as filed by SG Blocks, Inc.
−Removed: with the Securities and Exchange Commission on May 11, 2020 (File No.
−Removed: Consulting Agreement, dated April 13, 2020, by and between SG Blocks, Inc.
−Removed: and Stevan Armstrong (incorporated herein by reference to Exhibit 10.1 of the Current Report on Form 8-K as filed by SG Blocks, Inc.
−Removed: with the Securities and Exchange Commission on April 15, 2020 (File No.
−Removed: Distributorship Agreement between Osang Healthcare Co., Ltd.
−Removed: and SG Blocks, Inc., effective as of April 28, 2020 (incorporated herein by reference to Exhibit 10.1 of the Current Report on Form 8-K as filed by SG Blocks, Inc.
−Removed: with the Securities and Exchange Commission on May 5, 2020 (File No.
−Removed: Amendment to Distributorship Agreement between Osang Healthcare Co., Ltd.
−Removed: and SG Blocks, Inc., dated April 30, 2020 (incorporated herein by reference to Exhibit 10.2 of the Current Report on Form 8-K as filed by SG Blocks, Inc.
−Removed: with the Securities and Exchange Commission on May 5, 2020 (File No.
−Removed: Agreement between Osang Group Co.
−Removed: and SG Blocks, Inc., dated May 1, 2020 (incorporated herein by reference to Exhibit 10.3 of the Current Report on Form 8-K as filed by SG Blocks, Inc.
−Removed: with the Securities and Exchange Commission on May 5, 2020 (File No.
−Removed: Amendment No.
−Removed: 2 to the SG Blocks, Inc.
−Removed: Stock Incentive Plan (incorporated by reference to Appendix A to the Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on June 25, 2020 (File No.
−Removed: Email from Mahesh Shetty, dated June 19, 2020 (incorporated herein by reference to Exhibit 10.3 of the Current Report on Form 8-K as filed by SG Blocks, Inc.
−Removed: with the Securities and Exchange Commission on June 22, 2020 (File No.
+Added: with the Securities and Exchange Commission on September 22, 2020 (File No.
Certification by Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
11 unchanged sentences
SG BLOCKS, INC.
−Removed: August 13, 2020
+Added: November 19, 2020
Chief Executive Officer and Chairman of the Board
(Principal Executive Officer)
+Added: /s/ Gerald A.
+Added: Acting Chief Financial Officer
+Added: (Principal Financial Officer and Principal Accounting Officer)
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.